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Abstract
Previous work has shown that plasmid DNA can be encapsulated in small ‘stabilized plasmid-lipid particles’ (SPLP)
composed of 1,2-dioleyl-3-phosphatidylethanolamine (DOPE), the cationic lipid N,N-dioleyl-N,N-dimethylammonium
chloride (DODAC) and poly(ethylene glycol) (PEG) conjugated ceramides (PEG-Cer), employing a detergent dialysis
procedure. These SPLP have potential as vectors for in vivo gene therapy. This study is aimed at characterizing the influence
of the cationic lipid and PEG-Cer species on SPLP formation and in vitro transfection properties. It is shown that the
transfection potency of SPLP is sensitive to the cationic lipid species employed, the size of the PEG polymer incorporated in
the PEG-ceramide and the length of the acyl chain contained in the ceramide anchor. With regard to the influence of cationic
lipid, the transfection levels achieved were highest for SPLP containing N-[2,3-(dioleyloxy)propyl]-N,N-dimethyl-N-
cyanomethylammonium chloride (DODMA-AN) and lowest for SPLP containing 3-L-[N-(NP,NP-dimethylaminoethyl)car-
bamoyl]-cholesterol (DC-CHOL), according to the series DODMA-ANsN-[2,3-(dioleyloxy)propyl]-N,N,N-trimethylam-
monium chloride (DOTMA)sDODACsN,N-distearyl-N,N-dimethylammonium chloride (DSDAC)sDC-CHOL.
Incorporation of short (PEG750) PEG polymers in the PEG-ceramide components resulted in modest improvements in
transfection levels over PEG2000 and PEG5000 polymers, however variation of the length of the acyl chain contained in the
hydrophobic ceramide anchor from octanoyl (PEG-CerC8) to myristoyl (PEG-CerC14) to arachidoyl (PEG-CerC20) had the
most dramatic effects. Transfection levels achieved for SPLP containing PEG-CerC8 were substantially larger than observed
for SPLP containing PEG-CerC14 or PEG-CerC20, consistent with a requirement for the PEG-ceramide to dissociate from
the SPLP surface for maximum transfection potency. It is also shown that the ability of SPLP to be accumulated into cells is
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Abbreviations: L-gal, L-galactosidase; BHK, baby hamster kidney; CAT, chloramphenicol acetyltransferase; 14C-CHE, 14C-labeled
cholesteryl hexadecyl ether; CMC, critical micellar concentration; CMV, cytomegalovirus; DC-CHOL, 3-L-[N-(NP,NP-dimethylamino-
ethyl)carbamoyl]-cholesterol ; DEAE-Sepharose, diethylaminoethyl-Sepharose; DODAC, N,N-dioleyl-N,N-dimethylammonium chloride;
DODMA-AN, N-[2,3-(dioleyloxy)propyl]-N,N-dimethyl-N-cyanomethylammonium chloride; DOPE, 1,2-dioleoyl-3-phosphatidylethanol-
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chloride; HEPES, N-(2-hydroxyethyl)piperazine-NP-2-ethanesulfonic acid; 3H-pCMVCAT, 3H-labeled pCMVCAT plasmid; LUVs, large
unilamellar vesicle system; OGP, n-octyl-L-D-glucopyranoside; pCMVLgal, pCMVLgal plasmid; pCMVCAT, pCMVCAT plasmid; PEG-
CerC8, 1-O-(2P-(g-methoxypolyethyleneglycol2000)succinoyl)-2-N-octanoylsphingosine; PEG-CerC14, 1-O-(2P-(g-methoxypolyethylene-
glycol2000)succinoyl)-2-N-myristoylsphingosine; PEG-CerC20, 1-O-(2P-(g-methoxypolyethyleneglycol2000)succinoyl)-2-N-arachidoyl-
sphingosine; PEG750-CerC14, 1-O-(2P-(g-methoxypolyethyleneglycol750)succinoyl)-2-N-myristoylsphingosine; PEG5000-CerC14, 1-O-(2P-
(g-methoxypolyethyleneglycol5000)succinoyl)-2-N-myristoylsphingosine; QELS, quasi-elastic light scattering
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a dominant factor influencing transfection potency, and that the transfection potency of SPLP that are accumulated is at
least equivalent to that of cationic lipid-plasmid DNA complexes. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Plasmid DNA-cationic liposome complexes have
considerable utility as non-viral gene transfer systems
[1,2]. However, complexes are large, charged, hetero-
geneous structures that have limited utility in certain
applications. For example, the large size and positive
charge of complexes results in rapid clearance from
the circulation following intravenous injection,
largely limiting transfection to ‘¢rst pass’ organs
such as the lung, liver or spleen [1^6]. In this regard
recent work employing a detergent dialysis technique
[7] has shown that plasmid DNA can be encapsu-
lated in ‘stabilized plasmid-lipid particles’ (SPLP)
that are stabilized in aqueous media by the presence
of a poly(ethylene glycol) (PEG) coating. These par-
ticles are small (diameter approximately 70 nm), con-
tain high (s 80 mol%) levels of the ‘fusogenic’ lipid
dioleylphosphatidylethanolamine (DOPE), low (6 10
mol%) levels of the cationic lipid N,N-dioleyl-N,N-
dimethylammonium chloride (DODAC), protect en-
capsulated plasmid from degradation by serum nu-
cleases, and are well-de¢ned and stable systems con-
taining one plasmid per particle [7].
The transfection potency of SPLP as generated by
Wheeler et al. [7] is limited. However, SPLP are £ex-
ible systems that can potentially be constructed from
a variety of compounds, the choice of which may
strongly a¡ect transfection properties. Such com-
pounds include the cationic lipid contained in the
SPLP and the PEG coating surrounding the SPLP.
For example, plasmid DNA-cationic lipid complexes
which contain di¡erent cationic lipids can exhibit
markedly di¡erent transfection properties both in vi-
tro and in vivo [6,8^12]. Alternatively, it has been
shown that the presence of PEG coatings on vesicles
can dramatically inhibit intervesicular contact and
fusion [13]; and the presence of PEG-PE in DNA-
cationic lipid complexes can dramatically reduce in
vivo transfection activity [14].
In this work we investigate the in£uence of di¡er-
ent species of cationic lipid and PEG coatings on
the formulation and in vitro transfection
properties of SPLP. It is shown that whereas the
SPLP formulation process is relatively independent
of the (monovalent) cationic lipid species employed,
the highest levels of expression are observed for N-
[2,3-(dioleyloxy)propyl]-N,N-dimethyl-N-cyanometh-
ylammonium chloride (DODMA-AN). Alternatively,
incorporation of shorter acyl groups in the ceramide
which ‘anchors’ the PEG to the SPLP surface, which
results in rapid dissociation of the PEG from the
SPLP surface, dramatically improves transfection
levels. Finally, it is shown that low levels of cellular
uptake is a dominant parameter modulating the
transfection potential of SPLP, and that the intrinsic
transfection potency of SPLP that are taken up is at
least equivalent to that exhibited by complexes.
2. Materials and methods
2.1. Lipids and chemicals
N,N-Dioleyl-N,N-dimethylammonium chloride
(DODAC), N-[2,3-(dioleyloxy)propyl]-N,N-dimeth-
yl-N-cyanomethylammonium chloride (DODMA-
AN), N,N-distearyl-N,N-dimethylammonium chlo-
ride (DSDAC), 3-L-[N-(NP,NP-dimethylaminoethyl)-
carbamoyl]-cholesterol (DC-CHOL) were obtained
from Dr. S. Ansell (Inex Pharmaceuticals, Burnaby,
B.C., Canada). 1-O-(2P-(g-methoxypolyethylenegly-
col2000)succinoyl)-2-N-octanoylsphingosine (PEG-
CerC8), 1-O-(2P-(g-methoxypolyethyleneglycol2000)-
succinoyl)-2-N-myristoylsphingosine (PEG-CerC14),
1-O - (2P- (g -methoxypolyethyleneglycol2000)succi-
noyl)- 2-N-arachidoylsphingosine (PEG-CerC20), 1-O-
(2P-(g-methoxypolyethyleneglycol750)succinoyl)-2-
N-myristoylsphingosine (PEG750-CerC14), 1-O-(2P-
(g-methoxypolyethyleneglycol5000)succinoyl)-2-N-
myristoylsphingosine (PEG5000-CerC14) were ob-
tained from Dr. Z. Wang (Inex), and N-[2,3-(dioleyl-
oxy)propyl]-N,N,N-trimethylammonium chloride
(DOTMA) was synthesized as described in previous
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work [15]. 1,2-Dioleoyl-3-phosphatidylethanolamine
(DOPE) was purchased from Avanti Polar Lipids
(Alabaster, AL, USA). 14C-labeled cholesteryl hexa-
decyl ether (14C-CHE) was obtained from DuPont
NEN Products (Boston, MA, USA). Spectra/Por 2
molecular-porous membrane tubing (MW 12 000^
14 000) was purchased from VWR Scienti¢c (Edmon-
ton, Alta, Canada). Magnesium sulfate, L-mercap-
toethanol, potassium acetate, potassium chloride, so-
dium acetate, sodium phosphate, sodium chloride,
sodium hydroxide, and sucrose were obtained from
Fisher Scienti¢c (Fair Lawn, NJ, USA). Ampicillin,
bovine serum albumin (BSA), ethylenediaminetetra-
acetic acid (EDTA), N-(2-hydroxyethyl)piperazine-
NP-2-ethanesulfonic acid (HEPES), lithium chloride
(LiCl), lysozyme, n-octyl-L-D-glucopyranoside
(OGP), poly(ethylene glycol) (PEG8000), sodium do-
decyl sulfate, tris(hydroxymethyl)aminomethane
(Tris), diethylaminoethyl (DEAE) Sepharose CL-6B
anion exchanger, and Sepharose CL-4B resins were
obtained from Sigma (St. Louis, MO, USA). Bacto-
tryptone and bacto-yeast extract were purchased
from Difco (Detroit, MI, USA). All organic solvents
were purchased from Fisher Scienti¢c (Nepeau, Ont.,
Canada). Agarose was purchased from Bio-Rad
(Richmond, CA, USA). Aquacide II was purchased
from Calbiochem (La Jolla, CA, USA). Glycerol and
glucose were obtained from BDH (Toronto, Ont.,
Canada). Dulbecco’s modi¢ed Eagle’s medium
(DMEM), fetal bovine serum (FBS) and penicillin-
streptomycin were purchased from Gibco BRL (Bur-
lington, Ont., Canada). Chlorophenol red galacto-
pyranoside (CPRG) was purchased from Boehringer
Mannheim (Germany). Scintillation £uid (Ultima
Gold grade) was obtained from Packard Instrument
(Downers Grove, IL, USA). XhoI and HindIII re-
striction endonuclease and ribonuclease I ‘A’ from
bovine pancreas (RNase) were purchased from Phar-
macia Biotech (Uppsala, Sweden). BHK cells (BHK
21) were obtained from American Tissue Culture
Collection (ATCC CCL-10). Distilled water was pu-
ri¢ed from Corning Mega-Pure MP-4S system.
2.2. Plasmid
pCMVCAT plasmid, initially obtained from Inex,
and pCMVLgal plasmid, initially purchased from
Clontech, were ampli¢ed in Escherichia coli (DH5K)
with the selection of resistance to ampicillin, and
were isolated by alkali lysis and puri¢ed by PEG
precipitation as described elsewhere [15,16]. The pu-
rity of pCMVCAT and pCMVLgal was con¢rmed by
1% agarose gel electrophoresis with restriction endo-
nuclease XhoI or HindIII digest, respectively. The
plasmid concentration was determined by using
standard phosphorus assays [17] and was expressed
as phosphorus concentration of plasmid DNA. 3H-
labeled pCMVCAT was obtained from A. Annuar
(Inex).
2.3. Preparation of vesicles
Mixtures of lipids dispensed in chloroform were
dried under a stream of nitrogen gas with continuous
vortex mixing. The residual solvent was removed
under high vacuum for 2 h. The resulting lipid ¢lms
were hydrated with 150 mM NaCl, 20 mM HEPES
(pH 7.4) bu¡er and then freeze-thawed ¢ve times to
produce multilamellar vesicle (MLV) systems. Large
unilamellar vesicle system (LUVs) were obtained by
extruding MLVs 10 times through two 100-nm pore
size polycarbonate ¢lters (Costar Nuclepore) under
nitrogen at a pressure of 300^400 psi [18]. The size
of the LUVs was checked by quasi-elastic light scat-
tering (QELS) employing a Nicomp model 270 sub-
micron particle sizer operating in the vesicle mode.
Phosphorus assays were used to quantify phospholi-
pid concentration [17].
2.4. Preparation of plasmid DNA-cationic lipid
complexes
Plasmid DNA-cationic lipid complexes were
formed by incubating appropriate amounts of
preformed DOTMA/DOPE (1:1) LUVs with
pCMVLgal to obtain the desired charge ratio (posi-
tive-to-negative) of 1.0 in 100 Wl distilled water. The
resulting mixture was incubated at room temperature
for 20^30 min, and was then mixed with an equal
volume of culture media (see below).
2.5. Preparation of stabilized plasmid-lipid particles
(SPLP)
SPLP were prepared employing the method of
Wheeler et al. [7] with modi¢cations. Brie£y, for
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each preparation, appropriate amounts of cationic
lipid dissolved in chloroform were dried under a
stream of nitrogen gas. Similarly, appropriate
amounts of DOPE, PEG-ceramide and trace
amounts of 14C-CHE (as the lipid marker) were
mixed in chloroform and dried. Residual solvent
was removed under high vacuum for 2 h. The result-
ing lipid ¢lms were hydrated separately. n-Octyl-L-D-
glucopyranoside (OGP, 50 Wl of a 1.0 M solution)
was added to the dried cationic lipid followed by
brief vortexing. Subsequently 200 Wl of an aqueous
solution containing appropriate amounts of NaCl,
pCMVCAT and trace amounts of 3H-pCMVCAT
was added. Unless indicated otherwise, 25 Wg
pCMVCAT and 5.0 Wmol total lipids in 0.5 ml total
volume were used for each preparation in the entrap-
ment studies. After thorough mixing, the clear homo-
genous mixture was incubated at room temperature
for 30 min. A ¢nal concentration of 200 mM OGP in
150 mM NaCl was used for each preparation. The
lipid-containing medium was made by adding 250 Wl
of 200 mM OGP in 150 mM NaCl to the dried
DOPE/PEG-Cer/14C-CHE. After mixing and incu-
bating at room temperature for 30 min, a clear ho-
mogeneous mixture was obtained. The two mixtures
were then mixed together and transferred into a 6 cm
Spectra/Por 2 molecular-porous membrane tubing
(MW 12 000^14 000) for dialysis for 40 h against
two changes of a 150 mM NaCl, 5 mM HEPES
(pH 7.4) bu¡er. The SPLP thus formed were then
puri¢ed by DEAE anion exchange chromatography
and sucrose density gradient centrifugation as indi-
cated below, and characterized with respect to plas-
mid entrapment and size. All experiments involved
triplicate samples. For the transfection studies, sam-
ples of SPLP containing pCMVLgal were prepared
similarly with the exception that 400 Wg pCMVLgal,
10 Wmol total lipids, and a total volume of 1.0 ml
were used initially.
2.6. Quanti¢cation of DNA entrapment and lipid
recovery using anion exchange column
chromatography
A column chromatography procedure employing
DEAE-Sepharose CL-6B to remove free DNA was
utilized [7]. The average of two 40 Wl aliquots of the
SPLP dialysate radioactivity was used as a reference
for 3H and 14C radioactivity. The SPLP solution
(100 Wl of the dialysate) was applied to the DEAE-
Sepharose column (diameter 1.0 cm, height 1.5 cm)
and eluted using 150 mM NaCl, 20 mM HEPES (pH
7.4) bu¡er. Six fractions of 10 droplets each were
collected in scintillation vials and were counted for
3H and 14C radioactivity. The percentage of recovery
was obtained by comparing the total eluant radio-
activity with the reference radioactivity after back-
ground correction. Thus the 3H recovery represents
the fraction of DNA associated with the SPLP and
sequestered from the anion exchanger, whereas the
14C recovery represents the fraction of lipid in the
void volume. Free plasmid DNA bound to the col-
umn could be washed out using 10 ml of a 5.0 M
NaCl solution. A Beckman LS3801 scintillation
counter was used for all radioactivity measurements.
2.7. Puri¢cation of SPLP using sucrose density
gradient centrifugation
All samples of SPLP used for transfection were
further puri¢ed using sucrose density gradient centri-
fugation [7]. SPLP were prepared as outlined above
with 400 Wg pCMVLgal and 10 Wmol total lipids in a
total volume of 1.0 ml and free DNA was removed
by passing through a DEAE column. The diluted
eluant (3 ml) was transferred to a dialysis bag and
brie£y dried by placing Aquacide II around the bag.
After the desired volume was reached, the contents
were dialyzed overnight in 150 mM NaCl, 5 mM
HEPES (pH 7.4) bu¡er. The concentrated eluant
(800 Wl) was then subjected to sucrose density gra-
dient centrifugation (160 000Ug for 2.5 h). The gra-
dient was formed by loading 3.67 ml each of 1.0%,
2.5%, and 10% sucrose in 150 mM NaCl, 20 mM
HEPES, pH 7.4 bu¡er into a centrifuge tube (Beck-
man Ultra-Clear Tubes) using a drawn out glass pip-
ette. The crude SPLP preparation was then applied
to the top of the gradient and centrifuged using a
swinging bucket rotor (SW-41Ti) in an ultracentri-
fuge (Beckman L2-65B). Following centrifugation,
a band of concentrated SPLP with high DNA con-
tent was observed at the interface between the 2.5%
and 10% sucrose gradient levels. The fractionation
pro¢le was achieved by removing 250 Wl fractions
from the top of the gradient, and these fractions
were counted for 3H and 14C radioactivity. An ali-
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quot (100 Wl) of the sample before density gradient
separation was also counted as a reference. For the
transfection studies, the band corresponding to the
SPLP with high DNA content was isolated using
needle suction. The resulting puri¢ed SPLP were
concentrated by Aquacide II treatment as outlined
above, and then dialyzed against 150 mM NaCl,
5 mM HEPES (pH 7.4) with one change of bu¡er.
Quanti¢cation of DNA and lipid was performed by
comparing the 3H and 14C radioactivity of the puri-
¢ed SPLP against the radioactivity of crude SPLP
before sucrose density gradient. The overall recov-
eries of DNA and lipid were computed by multiply-
ing the recovery from the DEAE column by the re-
covery from sucrose density gradient. For size
analysis, puri¢ed SPLP were transferred into a
6U50 mm borosilicate glass tube and placed in a
Nicomp Model 270 submicron particle sizer, using
the particles mode of QELS.
2.8. Transfection studies employing BHK cells
The transfection protocol of Felgner et al. [11] was
employed with certain modi¢cations. Puri¢ed SPLP
were prepared as described above. Transfection stud-
ies employing SPLP were conducted on samples con-
taining 2.0 Wg pCMVLgal. This high amount of plas-
mid could be employed due to the low toxicity of
SPLP. Complexes (charge ratio of 1.0) were formed
by incubating DOTMA/DOPE (1:1) vesicles with ap-
propriate amounts of pCMVLgal for 30 min before
transfection, as outlined in previous work [15].
Transfection studies employing complexes used
0.5 Wg plasmid. All transfection studies were per-
formed in triplicate. Standards of L-galactosidase
(L-gal) were prepared by two-fold serial dilutions of
200 mU L-gal with 0.5% BSA in phosphate bu¡ered
saline (PBS) (pH 8.0). First, BHK 21 cells cultured in
DMEM with 10% fetal bovine serum (FBS) and
100 units of penicillin and 100 Wg streptomycin
were plated onto a 96 well plate with 2U104 cells
per well. Wells used for the DNA standards were
not plated with cells. The plate was then incubated
for 20 h at 37‡C with 5% CO2. For each well con-
taining the cells, appropriate amounts of complexes
or SPLP were diluted with DMEM/FBS, and ali-
quots of 100 Wl were used for transfection at 37‡C,
5% CO2 with incubation time of 4 or 24 h, respec-
tively. For the 4 h transfection studies, the trans-
fected media was removed, and 100 Wl of DMEM/
FBS was added. The cells were further incubated for
20 h at 37‡C, 5% CO2. After incubation, the incu-
bated media was removed, and the cells were lysed
by adding 50 Wl of lysis bu¡er containing 0.1% Tri-
ton X-100 in 250 mM phosphate bu¡er (pH 8.0) and
were freeze-thawed (370‡C) to ensure complete lysis.
After thawing, aliquots of 10 Wl of the lysis bu¡er
was transferred to another 96 well plate for protein
analysis. The remaining samples were assayed for
L-gal activity. Brie£y, 50 Wl of PBS containing 0.5%
BSA or 50 Wl of appropriate L-gal standard (0^100
mU) was added. Color development was induced by
adding 150 Wl of the substrate bu¡er containing
chlorophenol red galactopyranoside (CPRG) (1 mg/
ml), 60 mM Na2HPO4, 1 M MgSO4, 10 mM KCl,
and 50 mM L-mercaptoethanol. For the protein as-
say, 50 Wl of BSA standard (0^20 Wg) was prepared
by serial dilution in lysis bu¡er. An additional 40 Wl
of lysis bu¡er was added to the 10 Wl sample aliquot.
The BCA reaction mixture was prepared according
to established protocols from Pierce (Rockford, IL,
USA) prior to the assay, and 100 Wl of this mixture
was added to each well, including the protein stand-
ards. The plate was incubated at 37‡C for 2 h or
until the color was developed. The amounts of
L-gal and protein were quanti¢ed against the stand-
ard, after volume adjustment, and the L-gal activity
was expressed as mU of L-gal per mg of protein. All
absorbance readings were measured at 540 nm using
a Microplate Autoreader EL-309 (Bio-Tek Instru-
ments). For the transfection of SPLP formed with
di¡erent PEG-Cer, 1U105 BHK cells were plated
in a 24 well plate. Aliquots of 60 Wl and 10 Wl were
used for the BSA and BCA assay, respectively.
2.9. Cellular uptake studies of plasmid DNA
BHK cells were plated at a density of 5U105 cells
per 25 cm2 T-£ask the day before transfection. For
each transfection, complexes containing 2 Wg
pCMVLgal at a charge ratio of 1.0 were formed by
incubating DOTMA/DOPE (1:1) LUVs with
pCMVLgal for 20^30 min at room temperature be-
fore transfection. Puri¢ed SPLP samples (DOPE/
DOTMA/PEG2000-CerC8, 73:7:20) containing 2 Wg
pCMVLgal were also used for each transfection.
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Both plasmid DNA-cationic lipid complexes and
SPLP samples were made up to a ¢nal volume of
2 ml with DMEM containing 10% FBS before apply-
ing to BHK cells. For the cells transfected with com-
plexes, the transfection medium was replaced with
complete DMEM after the 4 h incubation time point.
Cells transfected with the SPLP samples were incu-
bated in the transfection medium until the speci¢c
time point. All transfection studies were performed
in triplicate. The cellular uptake kinetics of the plas-
mid DNA were analyzed by terminating the trans-
fection process at 4, 8, 24, and 48 h. At each time
point, the transfection medium was removed. The
cells were washed twice with PBS, and then treated
with trypsin-EDTA (0.05% trypsin, 0.53 mM EDTA-
4Na from Gibco BRL). The cells were then washed
with an isotonic bu¡er (250 mM sucrose, 50 mM
HEPES, pH 7.2, 3 mM MgCl2) and were centrifuged
at 2000 rpm for 2 min in a Sorvall MC 12 V centri-
fuge. The resulting cell pellets were resuspended in
the isotonic bu¡er, and the number of cells was
counted using a hemacytometer. Then, the cells
were centrifuged at 2000 rpm for 2 min, and the
pellets were treated with the lysis bu¡er (10 mM
Tris, pH 7.5, 0.5% SDS, 1 mM EDTA) containing
Pronase E (1 mg/ml) at 37‡C overnight.
2.10. Southern blot analysis of delivered plasmid DNA
Genomic DNA was isolated from the BHK cells
transfected with DNA-cationic lipid complexes and
SPLP [16]. Brie£y, the cell lysates were extracted
twice with phenol/chloroform (1:1), then the DNA
was precipitated with 95% ethanol and resuspended
in Tris-EDTA bu¡er (10 mM Tris-HCl, pH 8.0, 1
mM EDTA) at 200 Wl per 1U106 cells. The recovery
of total genomic DNA was determined by measuring
the absorbance at 260 nm of the resuspended sam-
ples. Genomic DNA (5 Wg) from each sample was
loaded into a 1% agarose gel with a set of plasmid
DNA standards (0^5 ng). After size fractionation,
the agarose gel was incubated in a denaturing bu¡er
(1.5 M NaCl, 0.5 N NaOH) for 1 h, and then in a
neutralizing solution (1.5 M NaCl, 1 M Tris, pH 7.4)
for 45 min. The DNA fragments were transferred to
a nylon membrane by capillary blotting overnight
with 3 M NaCl, 0.3 M sodium citrate at pH 7.0.
The nylon membrane was then baked at 80‡C for
1 h prior to the hybridization procedure. A 32P-la-
beled plasmid DNA probe was prepared using the
T7QuickPrime kit (Pharmacia Biotech) with BamHI
cut pCMVLgal. This probe was then added to the
DNA blot and allowed to hybridize overnight at
68‡C. The blot was washed 3 times with 300 mM
NaCl, 30 mM sodium citrate (pH 7.0) containing
0.1% SDS and once with 30 mM NaCl, 3 mM so-
dium citrate (pH 7.0) containing 0.1% SDS. The blot
was then exposed for 2^4 h on a PhosphoImager
screen and subsequently scanned (Molecular Dynam-
ics-PhosphoImager SI). The amount of plasmid
DNA taken up into cells was normalized by dividing
the total plasmid DNA (pg) recovered by the total
genomic DNA (Wg).
3. Results
3.1. In£uence of cationic lipid species on formation of
SPLP
Previous work has shown that incubation of plas-
mid DNA with the lipid mixture DOPE, PEG2000-
CerC14 and the cationic lipid DODAC (84:10:6; mo-
lar ratios) in the presence of OGP followed by dial-
ysis results in the formation of SPLP that are capable
of low levels of transfection in vitro [7]. It is of in-
terest to determine whether SPLP can be formed us-
ing other cationic lipids, and whether this in£uences
transfection potency. Here we characterize SPLP for-
mation and plasmid entrapment achieved using
DOTMA, DODMA-AN, DSDAC, DODAC, and
DC-CHOL (for structures see Fig. 1) using a total
of 5.0 Wmol lipid and 25 Wg pCMVCAT plasmid. In
these systems the PEG-CerC14 content was held con-
stant at 10 mol% of total lipid, and the cationic lipid
content varied over the 0^20 mol% range. Plasmid
entrapment was assayed employing the DEAE anion
exchange column procedure detailed Section 2. As
shown in Fig. 2, optimum entrapment levels of ap-
proximately 60% were achieved for each of the cat-
ionic lipids used, the only di¡erence being that this
maximum entrapment was observed at slightly di¡er-
ent cationic lipid content depending on the cationic
lipid species. The optimal lipid composition (DOPE/
cationic lipid/PEG-CerC14 ; molar ratios) for plasmid
encapsulation was 83:7:10 for DOTMA and DOD-
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MA-AN, 82.5:7.5:10 for DSDAC and DODAC, and
81:9:10 for DC-CHOL. These SPLP exhibited par-
ticle sizes of 90 þ 20 nm as measured by QELS.
3.2. In£uence of the PEG polymer anchor on
formation of SPLP
The PEG coating of SPLP is likely to inhibit asso-
ciation with cells, thus reducing transfection e⁄-
ciency. Previous work has shown that SPLP con-
structed from PEG-CerC20 did not result in
appreciable transfection in vitro, whereas limited
transfection was observed for SPLP containing
PEG-CerC14 [7]. This was attributed to an ability
of the PEG-CerC14 to dissociate from the SPLP sur-
face. Here, we also examine the formulation and
transfection properties of SPLP containing PEG2000
polymers linked to ceramide anchors containing oc-
tanoyl acyl groups (PEG-CerC8). Results for SPLP
containing PEG-CerC14 and PEG-CerC20 are also
presented for comparison (for structures see Fig. 3).
Preliminary experiments suggested that more than
10 mol% of the PEG-CerC8 was required to achieve
optimal plasmid entrapment and, therefore, the en-
trapment pro¢le was generated as a function of
PEG-ceramide content rather than cationic lipid con-
tent. The detergent dialysis protocol was then applied
Fig. 2. Plasmid encapsulation e⁄ciency for the SPLP detergent
dialysis procedure as a function of cationic lipid content for a
variety of cationic lipids: (A) DOTMA (8), DODMA-AN (*),
(B) DSDAC (R), DODAC (F), and (C) DC-CHOL (b). SPLP
were prepared as described in Section 2, employing 25 Wg
pCMVCAT plasmid with 5 Wmol total lipid consisting of 10
mol% PEG-CerC14, x mol% cationic lipid, and 903x mol%
DOPE. Encapsulation was assayed by measuring DNA recovery
after passage of the dialysate through a DEAE Sepharose CL-
6B column (see Section 2). The average and standard deviation
from three individual experiments are shown.
Fig. 1. Structures of the cationic lipids used in this study.
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to systems containing 25 Wg pCMVCAT and 5.0
Wmol total lipids where the cationic lipid content
was maintained at 7.5 mol% DODAC. As shown
in Fig. 4, maximum entrapment levels are observed
at approximately 20 mol% PEG-CerC8, whereas the
maximum plasmid entrapment for the PEG-CerC14
and PEG-CerC20 systems are in the range of 10^12
mol% of the PEG-Cer.
3.3. In£uence of the PEG anchor on transfection
properties of SPLP
The transfection properties of SPLP were investi-
gated employing SPLP with entrapped pCMVLgal to
allow a convenient assay for transfection. Further,
the transfection protocol involved using puri¢ed
SPLP, where the empty vesicles produced during
the detergent dialysis procedure were removed by
density gradient centrifugation as detailed in Section
2. The initial set of experiments was designed to as-
certain appropriate transfection conditions for the
SPLP (DOPE/DOTMA/PEG-CerC8 ; 73:7:20; molar
ratios) system. As shown in Fig. 5A, protocols em-
ploying SPLP containing 0.5 Wg pCMVLgal gave lit-
tle or no transfection; however signi¢cant transfec-
tion was observed for SPLP containing 1.0 or 2.0 Wg
of plasmid DNA at transfection times of 24 h or
longer. Thus, a 24 h incubation time and 2.0 Wg
plasmid DNA was utilized for the standardized
SPLP transfection protocol in subsequent experi-
ments. It is of interest to compare the transfection
properties of SPLP with that achieved employing
plasmid DNA-cationic lipid complexes. As shown
in Fig. 5B, transfection of BHK cells employing
pCMVLgal-DOTMA/DOPE (1:1) complexes gave
transfection levels which are approximately an order
of magnitude higher than observed for the SPLP
preparation. In addition, good transfection activity
was observed at low (0.5 Wg pCMVLgal) plasmid
levels and at short (4 h) incubation times.
In order to characterize the in£uence of the ceram-
ide anchor on the transfection properties, SPLP con-
taining pCMVLgal were generated by using 400 Wg
pCMVLgal and 10 Wmol lipid mixtures. Lipid com-
positions of DOPE/DOTMA/PEG-Cer (83.5:6.5:10;
molar ratios) using the amide chain lengths of C8,
C14, and C20 were prepared. These systems were then
puri¢ed to remove empty vesicles employing the den-
sity centrifugation protocol, and the transfection
properties of the puri¢ed SPLP containing PEG-
CerC8, PEG-CerC14 and PEG-CerC20 in BHK cells
under standard transfection conditions (2 Wg
pCMVLgal; 24 h incubation) are illustrated in Fig.
6. A correlation between the transfection activities
and the length of the ceramide anchor is observed.
SPLP formed with PEG-CerC8 give rise to 30-fold
higher transfection activity than systems formed with
PEG-CerC14, which in turn results in 8-fold higher
transfection activity than SPLP formed with PEG-
CerC20.
3.4. In£uence of cationic lipid species on transfection
properties of SPLP
The transfection properties of SPLP containing the
di¡erent cationic lipids with 20% PEG-CerC8 are il-
Fig. 3. Structures of poly(ethylene glycol)-ceramides (PEG-Cer) used in this study.
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lustrated in Fig. 7. The standard SPLP transfection
protocol (2.0 Wg pCMVLgal; 24 h incubation time)
was utilized. It may be observed that the inclusion of
di¡erent cationic lipids in SPLP did lead to di¡erent
transfection activity, leading to the transfection po-
tency pro¢le of DODMA-ANsDOTMAsDO-
DACsDSDACsDC-CHOL.
Fig. 5. Transfection properties of SPLP and plasmid DNA-cati-
onic lipid complexes. (A) L-Gal expression in BHK cells result-
ing from incubation with SPLP containing 0.25 Wg pCMVLgal
(open bars), 1.0 Wg pCMVLgal (shaded bars), and 2.0 Wg
pCMVLgal (solid bars) for 4 and 24 h is shown. (B) L-Gal ex-
pression in BHK cells resulting from incubation with complexes
containing 0.25 Wg pCMVLgal (open bars), 0.50 Wg pCMVLgal
(shaded bars), and 1.0 Wg pCMVLgal (solid bars) for 4 and 24
h. SPLP (DOPE/DOTMA/PEG-CerC8 ; 73:7:20; molar ratios)
and plasmid DNA-cationic lipid complexes (DOTMA/DOPE
(1:1)-pCMVLgal; charge ratio of 1.0) were prepared from
pCMVLgal as described in Section 2. SPLP were puri¢ed em-
ploying the discontinuous sucrose density gradient centrifuga-
tion protocol. The average and standard deviation from tripli-
cates are shown.
Fig. 4. Plasmid encapsulation e⁄ciency for the SPLP detergent
dialysis procedure utilizing (A) PEG-CerC8, (B) PEG-CerC14
and (C) PEG-CerC20. SPLP were prepared as described in Sec-
tion 2 employing 25 Wg pCMVCAT formulated with 5.0 Wmol
total lipids containing 7.5 mol% DODAC, x mol% PEG-Cer,
and 92.53x mol% DOPE. Encapsulation was assayed by meas-
uring plasmid recovery after passage of the dialysate through a
DEAE Sepharose CL-6B column. The average and standard de-
viations calculated from three individual experiments are
shown.
BBAMEM 77612 6-7-99
K.W.C. Mok et al. / Biochimica et Biophysica Acta 1419 (1999) 137^150 145
3.5. In£uence of PEG polymer length on formation
and transfection properties of SPLP
An alternative approach to improve the transfec-
tion potency of SPLP is to reduce the length of the
PEG polymer associated with the ceramide anchor.
This was investigated for PEG-CerC14 molecules
containing PEG750, PEG2000 and PEG5000. Relatively
poor entrapment levels in the range of 40% were
achieved for the PEG750-CerC14 and PEG5000-CerC14
systems as compared to nearly 60% for the PEG2000-
CerC14 containing system (data not shown).
Transfection studies were performed on SPLP
formed initially with 400 Wg pCMVLgal and 10
Wmol total lipids composed of DOPE, DOTMA,
and PEG-CerC14 (83.5:6.5:10; molar ratios) for all
the PEG species. These preparations were then puri-
¢ed employing the density centrifugation procedure
and used to transfect BHK cells according to the
standard protocol. The transfection properties of
these SPLP containing PEG750-CerC14, PEG2000-
CerC14 and PEG5000-CerC14 are illustrated in Fig.
8. SPLP containing PEG750 have slightly higher in
vitro transfection potency than systems formed
with PEG2000 or PEG5000.
3.6. Comparison of intracellular delivery of plasmid
by SPLP and complexes
The results to this point indicate that SPLP con-
taining DODMA-AN, PEG anchors with shorter
amide chains and PEG coatings composed of shorter
Fig. 8. Transfection properties of SPLP containing PEG-ceram-
ides in which the size of the PEG polymer is varied (PEG750,
PEG2000 and PEG5000). L-Gal expression in BHK cells was as-
sayed following incubation with SPLP containing 2.0 Wg
pCMVLgal for 24 h. SPLP (DOPE/DOTMA/PEG-CerC14 ;
83.5:6.5:10; molar ratios) containing pCMVLgal were prepared
as indicated in Section 2. SPLP were puri¢ed employing the
discontinuous sucrose density gradient centrifugation protocol.
The average and standard deviation from triplicates are shown.
Fig. 7. Transfection properties of SPLP formed with the cati-
onic lipids DODMA-AN, DOTMA, DODAC, DSDAC, and
DC-CHOL and transfection achieved employing DOTMA-
DOPE complexes. SPLP composed of cationic lipid (DODMA-
AN and DOTMA, 7.0 mol%; DODAC and DSDAC, 7.5
mol%; DC-CHOL, 9.0 mol%), DOPE, and 20 mol% PEG-
CerC8 containing 2.0 Wg pCMVLgal, and pCMVLgal-DOTMA/
DOPE (1:1) complexes (charge ratio of 1.0; 0.5 Wg pCMVLgal)
were incubated with BHK cells and transfection assayed at 24
h. The average and standard deviation from triplicates are
shown.
Fig. 6. Transfection properties of SPLP containing PEG-CerC8,
PEG-CerC14 and PEG-CerC20. BHK cells were transfected with
SPLP composed of DOPE/DOTMA/PEG-Cer (83.5:6.5:10; mo-
lar ratios) and 2.0 Wg pCMVLgal for 24 h as outlined in Sec-
tion 2. SPLP were puri¢ed employing the discontinuous sucrose
density gradient centrifugation protocol. The average and
standard deviation from triplicates are shown.
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PEG polymers result in improved transfection of
BHK cells in vitro. However, in all cases the trans-
fection levels achieved are substantially lower than
those observed for plasmid DNA-cationic lipid com-
plexes. This may result from a reduced a⁄nity of
SPLP for cells due to the presence of the PEG coat-
ing on the SPLP and the much reduced positive
charge on the SPLP as compared to complexes.
Both of these e¡ects may act to substantially reduce
the amount of plasmid that is delivered to the cell. In
order to determine whether this could account for
the reduced transfection potency of SPLP as com-
pared to complexes, the time dependent cellular up-
take of pCMVLgal in both lipid-based DNA carriers
was investigated. SPLP were formed from 400 Wg
pCMVLgal and 10 Wmol total lipids composed of
DOPE/DOTMA/PEG-CerC8 (73:7:20; molar ratios)
and were puri¢ed by density centrifugation. Puri¢ed
SPLP samples (2 Wg pCMVLgal) and DNA-cationic
lipid complexes (DOTMA/DOPE (1:1)-pCMVLgal;
charge ratio of 1.0; 2.0 Wg pCMVLgal) were trans-
fected as outlined in Section 2. Plasmid DNA deliv-
ered by the complexes demonstrate rapid, high cellu-
lar uptake and subsequent degradation with
maximum plasmid levels at 4 h; whereas SPLP yield
maximum plasmid delivery at a 8^24 h incubation
(Fig. 9A). It may be noted that the maximum level
of plasmid delivered by complexes is more than
30 times that delivered by SPLP.
The integrity of the delivered plasmid DNA over
time is illustrated in Fig. 9B. Although the complexes
delivered much more plasmid, this plasmid was de-
graded more rapidly than that delivered by the SPLP
systems. This is indicated by the smears observed in
the DNA delivered by the complexes as shown in the
agarose gel electrophoretic pattern (Fig. 9B). This
indicates that plasmid DNA entrapped within the
particles is not as susceptible to degradation by cel-
lular enzymes as compared to plasmid DNA associ-
ated with complexes.
4. Discussion
This work was aimed at characterizing factors that
in£uence the transfection potency of stabilized plas-
mid-lipid particles with the aim of improving trans-
gene expression. It is shown that three factors that
can modulate SPLP transfection e⁄cacy are the spe-
cies of cationic lipid employed, the size of the PEG
polymer coating the SPLP and the length of the acyl
Fig. 9. Southern blot analysis of intracellular delivery of plas-
mid DNA by SPLP and plasmid DNA-cationic lipid complexes.
SPLP composed of DOPE/DOTMA/PEG-CerC8 (73:7:20; mo-
lar ratios) and complexes composed of DOTMA/DOPE (1:1)-
pCMVLgal (charge ratio of 1.0) were used. DNA transfection
and cellular uptake studies were performed as described in Sec-
tion 2. Comparison of the cellular uptake of plasmid DNA us-
ing DNA-cationic lipid complexes (b) and SPLP (F) is shown
in panel A. Southern blot analysis of the integrity of the plas-
mid DNA delivered by the two lipid-based DNA carriers is
shown in panel B. The average and standard deviation from
triplicates are shown.
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chain contained in the ceramide ‘anchor’. These fac-
tors are discussed in turn, followed by a discussion of
the implications of the observation that the low levels
of SPLP uptake into cells may be the primary pa-
rameter limiting transgene expression.
With regard to the in£uence of di¡erent cationic
lipids, the results presented here demonstrate that
plasmid encapsulation employing the detergent dial-
ysis process is relatively independent of the species of
monovalent cationic lipid employed. Although it is
di⁄cult to discern any de¢nite trends, DODMA-AN
and DOTMA appear to provide the maximum en-
trapment at the lowest cationic lipid content (V7%),
followed by DODAC and DSDAC (V7.5%) and
DC-CHOL (V9%). Interestingly, SPLP composed
of DODMA-AN and DOTMA exhibit signi¢cantly
higher transfection potencies than SPLP containing
DODAC, DSDAC or DC-CHOL (Fig. 7). These re-
sults could be taken to suggest that cationic lipids
with the greatest a⁄nity for plasmid DNA under
the conditions of detergent dialysis lead to the most
potent transfection systems. In any event, it is clear
that the species of cationic lipid does in£uence the
transfection capability of the resulting SPLP, with
DODMA-AN resulting in the highest transfection
levels and DC-CHOL the lowest, with DODAC
and DSDAC giving rise to intermediate transfection
levels.
The second factor which clearly plays a major role
in modulating the transfection potency of SPLP is
the length of the acyl chain contained in the hydro-
phobic ceramide group which anchors the PEG coat-
ing to the SPLP surface. Previous work has shown
that inclusion of PEG-CerC14 in SPLP results in en-
hanced expression in vitro as compared to SPLP
containing PEG-CerC20, however the levels of gene
expression were low in all cases [7]. The results pre-
sented here show that 30-fold higher transfection lev-
els can be achieved for SPLP containing PEG-CerC8
as compared to PEG-CerC14 (Fig. 6). This improved
transfection ability presumably re£ects a faster leav-
ing rate for the shorter chain PEG-ceramides from
the SPLP surface in the sequence PEG-
CerC8sPEG-CerC14sPEG-CerC20, leaving the
SPLP surface less shielded by PEG for the C8 con-
taining system. This e¡ect is fully consistent with
previous work showing that the half-time (t1=2) for
dissociation of PEG-CerC8 from LUV is less than
1.2 min [19], whereas PEG-CerC14 and PEG-CerC20
exhibit t1=2 values of 1.2 h and greater than 13 days,
respectively [7]. It is also consistent with the obser-
vation that fusion between LUVs can be inhibited by
the presence of a PEG coating anchored to PE mol-
ecules, and that fusogenicity could be restored by
using PE anchors with short acyl chains [13]. Other
workers have shown that the transfection potency of
plasmid DNA-cationic lipid complexes is signi¢-
cantly reduced by the presence of PEG-PE [14].
The ability of the PEG coating on SPLP to inhibit
transfection can arise due to reduced binding and
therefore reduced uptake into target cells, or reduced
e⁄ciency in fusing with the endosomal membrane in
order to achieve intracellular delivery of the plasmid.
The formulation properties of SPLP containing
PEG-CerC8 are clearly di¡erent from the properties
of SPLP containing longer chain ceramides, in that
optimum encapsulation is achieved at V20 mol%
PEG-CerC8 as compared to V10 mol% for SPLP
containing PEG-CerC14 or PEG-CerC20 (Fig. 4). It
is possible that the partition coe⁄cient of the shorter
chain PEG-CerC8 for the SPLP outer monolayer is
reduced, resulting in a requirement for a higher con-
centration of the PEG-CerC8 to achieve adequate
membrane levels for stabilization.
The third parameter, the length of the PEG poly-
mer, appears to in£uence the formulation properties
of the SPLP more than the transfection potency. The
transfection potency of SPLP containing PEG750,
PEG2000 and PEG5000 coupled to CerC14 are similar
(Fig. 8), however the formulation properties di¡er
signi¢cantly. In particular, the maximum e⁄ciency
for plasmid encapsulation that could be achieved
for SPLP containing PEG750 or PEG5000 was
V40%, as compared to V60% for the PEG2000 sys-
tem (data not shown). Reduced plasmid entrapment
for shorter PEG polymers would be expected due to
the reduced steric stabilizing capacity of the shorter
PEG polymers. The reason for the poorer entrap-
ment for the SPLP containing PEG5000-ceramide is
not currently understood. It may result from a higher
CMC of the PEG5000-ceramide due to the larger size
of the polar region, or to the interference of the
longer PEG polymer with the association of plasmid
with the lipid intermediates generated during forma-
tion of SPLP [7]. The fact that SPLP containing
PEG-ceramides with shorter PEG polymers do not
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exhibit signi¢cantly higher transfection potencies pre-
sumably re£ects the fact that the presence of PEG-
ceramides which are su⁄cient to stabilize formation
of the SPLP during the detergent dialysis process are
also su⁄cient to inhibit uptake into cells.
The ¢nal area of discussion concerns the observa-
tion that SPLP exhibit much lower levels of accumu-
lation into target cells as compared to plasmid DNA-
cationic lipid complexes, and that the plasmid deliv-
ered by SPLP remains intact in the cell for a longer
time following cellular uptake. With regard to the
¢rst point, when BHK cells are presented with equiv-
alent amounts of plasmid DNA in either the complex
form or in SPLP (DOPE/DOTMA/PEG-CerC8 ;
73:7:20; molar ratios) form, the maximum amount
of plasmid that is delivered into the cells by the SPLP
is less than 3% of the maximum amount delivered by
the plasmid DNA-cationic lipid complexes. Thus
even though the in vitro transfection potency of the
complexes (DOTMA/DOPE (1:1)-pCMVLgal;
charge ratio of 1.0; 2 Wg pCMVLgal) is at least 10-
fold higher than the SPLP (DOPE/DOTMA/PEG-
CerC8 ; 73:7:20; 2 Wg pCMVLgal; 24 h transfection),
the reduced potency of the SPLP can be attributed to
a 30-fold or more reduction in plasmid uptake as
compared to complexes. This reduced plasmid up-
take likely results from a low a⁄nity of the SPLP
particle for the cell membrane as compared to com-
plexes, although breakdown of SPLP-associated
plasmid could give similar results. The fact that pre-
vious studies [7] show SPLP plasmid to be highly
stable and the results presented here showing that
plasmid delivered to cells in SPLP is broken down
more slowly than plasmid in complexes suggests that
a low a⁄nity of the SPLP for the cell is the dominant
factor. In any event, the fact that the reduced po-
tency of SPLP as compared to complexes can be
attributed to low cellular uptake argues strongly
that SPLP exhibit an intrinsic ability to transfect cells
following uptake that is at least comparable to com-
plexes. These results also suggest that the most direct
way to improve the transfection properties of SPLP
is to enhance cellular uptake. This could be accom-
plished in a number of ways, including incorporation
of external targeting ligands to promote cell associa-
tion and uptake.
The second observation that plasmid delivered to
cells by SPLP is broken down at a much slower rate
than plasmid delivered in complexes presumably re-
£ects the resistance of the SPLP particle to break-
down by intracellular factors. It also points out the
potential for more stable particles such as SPLP to
extend the duration of transfection resulting from
transfection by non-viral gene delivery systems.
In summary, this investigation characterizes fac-
tors that regulate the transfection potency of stabi-
lized plasmid-lipid particles. It is shown that the
transfection potency is sensitive to both the cationic
lipid species and the species of PEG-ceramide em-
ployed to construct the SPLP. Improved transfection
activity can be achieved by the use of the cationic
lipid DODMA-AN, PEG-ceramides incorporating
smaller PEG polymers and, most importantly, the
use of PEG-ceramides containing shorter acyl groups
in the ceramide anchor. Further, it is shown that the
dominant factor leading to lower levels of transfec-
tion by SPLP is the low level of SPLP accumulation
by the target cells. These observations point the way
to achieve plasmid delivery systems that exhibit en-
hanced levels of gene expression for in vivo gene
therapy.
Acknowledgements
This work was supported by Inex Pharmaceuticals
Corporation and the Natural Sciences and Engineer-
ing Research Council of Canada under the Collabo-
rative Research and Development Program. We
thank L. Palmer from our laboratory and Dr. P.
Scherrer from Inex Pharmaceuticals Corporation
for technical consultation on SPLP preparation. We
would also like to thank Dr. S. Ansell from Inex for
the generous supply of di¡erent cationic lipids, Dr.
Z. Wang for the supply of di¡erent PEG-Cer, and A.
Annuar for the supply of 3H-pCMVCAT.
References
[1] N. Zhu, D. Liggitt, Y. Liu, R. Debs, Systemic gene expres-
sion after intravenous DNA delivery into adult mice, Science
261 (1993) 209^211.
[2] R.I. Mahato, K. Kawabata, T. Nomura, Y. Takakura, M.
Hashida, Physicochemical and pharmacokinetic characteris-
tics of plasmid DNA/cationic liposome complexes, J. Phar-
macol. Sci. 84 (1995) 1267^1271.
BBAMEM 77612 6-7-99
K.W.C. Mok et al. / Biochimica et Biophysica Acta 1419 (1999) 137^150 149
[3] I. Solodin, C.S. Brown, M.S. Bruno, C.-Y. Chow, E.-H.
Jang, R.J. Debs, T.D. Heath, A novel series of amphiphilic
imidazolinium compounds for in vitro and in vivo gene de-
livery, Biochemistry 34 (1995) 13537^13544.
[4] D.C. Litzinger, J.M. Brown, I. Wala, S.A. Kaufman, G.Y.
Van, C.L. Farrell, D. Collins, Fate of cationic liposomes and
their complex with oligonucleotide in vivo, Biochim. Bio-
phys. Acta 1281 (1996) 139^149.
[5] Y. Liu, L.C. Mounkes, H.D. Liggit, C.S. Brown, I. Solodin,
T.D. Heath, R.J. Debs, Factors in£uencing the e⁄ciency of
cationic liposome-mediated intravenous gene delivery, Na-
ture Biotechnol. 15 (1997) 167^173.
[6] N.S. Templeton, D.D. Lasic, P.M. Frederik, H.H. Strey,
D.D. Roberts, G.N. Pavlakis, Improved DNA:liposome
complexes for increased systemic delivery and gene expres-
sion, Nature Biotechnol. 15 (1997) 647^652.
[7] J.J. Wheeler, L. Palmer, M. Ossanlou, I. MacLachlan, R.
Graham, P. Scherrer, M.J. Hope, P.R. Cullis, Stabilized
plasmid-lipid particles: construction and characterization,
Gene Ther. 6 (1999) 271^281.
[8] X. Gao, L. Huang, A novel cationic liposome reagent for
e⁄cient transfection of mammalian cells, Biochem. Biophys.
Res. Commun. 179 (1991) 280^285.
[9] J.K. Rose, L. Buonocore, M.A. Whitt, A new cationic lip-
osome reagent mediating nearly quantitative transfection of
animal cells, BioTechniques 10 (1991) 520^525.
[10] W.R. Jarnagin, R.J. Debs, S.-S. Wang, D.M. Bissell, Cati-
onic lipid-mediated transfection of liver cells in primary cul-
ture, Nucleic Acids Res. 20 (1992) 4205^4211.
[11] J.H. Felgner, R. Kumar, C.N. Sridhar, C.J. Wheeler, Y.J.
Tsai, R. Border, P. Ramsey, M. Martin, P.L. Felgner, En-
hanced gene delivery and mechanism studies with a novel
series of cationic lipid formulations, J. Biol. Chem. 269
(1994) 2550^2561.
[12] N.K. Egilmez, Y. Iwanuma, R.B. Bankert, Evaluation and
optimization of di¡erent cationic liposome formulations for
in vivo gene transfer, Biochem. Biophys. Res. Commun. 221
(1996) 169^173.
[13] J.W. Holland, C. Hui, P.R. Cullis, T.D. Madden, Poly(ethy-
lene glycol)-lipid conjugates regulate the calcium-induced fu-
sion of liposomes composed of phosphatidylethanolamine
and phosphatidylserine, Biochemistry 35 (1996) 2618^2624.
[14] K. Hong, W. Zheng, A. Baker, D. Papahadjopoulos, Stabi-
lization of cationic liposome-plasmid DNA complexes by
polyamines and poly(ethylene glycol)-phospholipid conju-
gates for e⁄cient in vivo gene delivery, FEBS Lett. 400
(1997) 233^237.
[15] K.W.C. Mok, P.R. Cullis, Structural and fusogenic proper-
ties of cationic liposomes in the presence of plasmid DNA,
Biophys. J. 73 (1997) 2534^2545.
[16] J. Sambrook, E.F. Fritsch, T. Maniatis, Extraction and pu-
ri¢cation of plasmid DNA, in: C. Nolan (Ed.), Molecular
Cloning: A Laboratory Manual, Vol. I, Cold Spring Harbor
Laboratory Press, Cold Spring Harbor, NY, 1989, pp. 1.21^
1.52, 5.28^5.32, and 6.3^6.19.
[17] C.H. Fiske, Y. Subbarow, The colorimetric determination of
phosphorus, J. Biol. Chem. 66 (1925) 375^379.
[18] L.D. Mayer, M.J. Hope, P.R. Cullis, Vesicles of variable
sizes produced by a rapid extrusion procedure, Biochim.
Biophys. Acta 858 (1986) 161^168.
[19] J.W. Holland, M.A. Monck, L.S. Choi, P.R. Cullis, T.D.
Madden, Programmable fusion between cationic liposomes
and a eukaryotic plasma membrane, J. Biol. Chem. (1999)
(submitted).
BBAMEM 77612 6-7-99
K.W.C. Mok et al. / Biochimica et Biophysica Acta 1419 (1999) 137^150150
